This is also true for the other agents like liraglutide and sitagliptin.

其他药物如利拉鲁肽和西格列汀也是如此。

Two-year assessment of the efficacy and safety of sitagliptin in elderly patients with type 2 diabetes: Post hoc analysis of the ASSET-K study.

与老年2型糖尿病患者的疗效评估西他列汀两年：事后分析的asset-k研究。